MENU
AEZS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AEterna Zentaris (AEZS) Ownership - Who owns AEterna Zentaris?

AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of significant unmet medical need... Show more

Profile

Industry
N/A
Address
c/o Norton Rose Fulbright Canada, LLP
Phone
+1 416 216-4000
Employees
21
Web
https://www.zentaris.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.41M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
8.91M
Risk (Beta)
0.75
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
3.50 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
c/o Norton Rose Fulbright Canada, LLP
Phone
+1 416 216-4000
Employees
21
Web
https://www.zentaris.com